Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 07 November 2012 | By Alexander Gaffney, RAC,
Some people get invitations to appear before Congress; others, subpoenas. Barry Cadden, co-owner of the New England Compounding Center (NECC), is of the latter category.
The House Energy and Commerce (E&C) Committee announced on 6 November that it had sent a subpoena to Cadden, whose company has been linked to an outbreak of fungal meningitis that has claimed the lives of dozens of patients and made hundreds more ill.
The E&C Committee has scheduled a high-profile hearing to discuss whether there are lessons to be learned from the outbreak and to determine culpability for the crisis.
Though legislators said they had sought Cadden's voluntary cooperation, they said he indicated he would not appear willingly through his legal counsel, necessitating the subpoena.
"With more than 400 people infected and 30 deaths, it is critical that we hear directly from the head of the facility linked to the outbreak," wrote E&C Chairman Fred Upton (R-MI) and Ranking Member Henry Waxman (D-CA) in a joint statement. "Since Mr. Cadden has indicated he will not appear voluntarily, we are left with no choice but to issue a subpoena. We urge Barry Cadden to put the public health first and answer the committee's questions about the deadly outbreak."
The hearing could be one of the highest profile in the waning months of the 112th Congress. The scandal has received prominent and sustained media attention, and US Food and Drug Administration Commissioner Margaret Hamburg is also scheduled to appear-albeit willingly-at the 14 November hearing.
Tags: Legislature, Cadden, Outbreak, NECC, Meningitis, Energy and Commerce, House, Latest News, Hamburg, Congress
Regulatory Focus newsletters
All the biggest regulatory news and happenings.